Arkolith/Insider Trading/RLAY/Form 4

Rahmer Peter

See remarksRelay Therapeutics, Inc. (RLAY) · full profile →Form 4 · filed Jul 30, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$63K
Net Open-Market Flow
-$63K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 29, 2025Sell(S)16K$3.68$58K378K
Jul 28, 2025Sell(S)1K$3.74$5K394K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-100367) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML